Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
Palo Alto Networks has given back 5.4% this week to trade at $397.03, reversing part of a remarkable one-month gain of 20%, and the most interesting tension in the setup is what the analyst community chose to do during the selloff.
Wells Fargo's Michael Turrin raised his price target from $475 to $525 on October 13, the day the stock fell 1.7%. That is the most aggressive published target in recent changes and sits 32% above Tuesday's close. It follows a pattern of constructive Street behaviour through September and into October: TD Cowen lifted to $440 from $400 on October 2, BTIG raised to $425 from $404 on September 28, and Morgan Stanley nudged its Overweight target to $410 from $394 on September 21. The consensus mean price target is $397.92, barely above the current price, which reflects a wider distribution than the bullish moves suggest. The outlier pulling the average down is Bernstein, which downgraded to Market Perform on September 17 with a $351 target after raising it sharply from $253. Amerx initiated at Hold on October 8 with no price target attached. The dominant direction of travel on the Street is higher, but the valuation debate is real.
The bull case rests on platformization momentum: a record 220 net new platform deals, 120% net revenue retention among converted customers, and management targeting $20 billion in next-generation security ARR by 2030. The bear case points to decelerating core growth, with reported FY26 growth slowing to 13.0% in the fourth quarter from 14.1% in the third, and FY27 guidance implying a step down to 14.5% pro forma revenue growth. The EV/EBITDA multiple sits at 59x and the trailing PE is 84x, both compressing modestly over the past week as the stock has pulled back. The 90-day EPS estimate momentum factor ranks in the 86th percentile, meaning forward estimates are still moving up. The 12-month forward year-over-year EPS growth factor ranks in the 88th percentile. Those readings sit uncomfortably alongside an EV/EBIT percentile rank of just 2, which reflects how expensive the stock remains relative to its current earnings base.
Short positioning has edged up this week but remains a minor factor. Short interest rose 8.2% over the past five sessions to 3.1% of the free float, reversing a decline through September and October that had pushed it from roughly 3.2% down to 2.8%. At this level, it is not a structural overhang. The borrow market confirms that: availability is extremely loose at roughly 6,100%, meaning shares available to lend dwarf the outstanding short position by a wide margin. Borrowing costs are 0.47%, trivially cheap. The options market has also come off the defensive readings seen through September. The put/call ratio is 0.85, slightly below its 20-day mean of 0.87, sitting about 0.9 standard deviations toward the call side of average. That is a mild bullish lean, not a conviction signal in either direction.
The insider register is worth noting, though largely for the absence of buying rather than any aggressive selling signal. The CFO, Dipak Golechha, sold approximately $6.7 million in shares on September 24 under a pre-arranged 10b5-1 plan, a scheduled disposal rather than a discretionary trade. The Chief Accounting Officer made smaller 10b5-1 plan sales on October 1. Net insider activity over 90 days is minus $20.8 million in value across minus 54,210 shares, weighted entirely toward plan-driven sales. No open-market purchases appear in the recent data. BlackRock holds 9.3% of shares and added 3.3 million shares in the most recent reported period. JP Morgan Asset Management added 6.2 million shares. FMR (Fidelity) added 11 million shares, the largest single institutional addition in the top-holder list. These are passive and active flows that point to continued institutional accumulation, though the data reflects positions as reported through September.
PANW reports its next quarter on November 13, 30 days away. The last print on September 1 sent the stock down 14% on the day and an additional 12% over the following week, a reaction that stands as a caution against assuming the fundamental narrative translates cleanly into post-earnings price action. The week between now and that report, and how the stock holds or reclaims ground after this week's pullback, will test whether the Wells Fargo $525 thesis has genuine near-term traction or remains a post-2030 story priced in too early.
See the live data behind this article on ORTEX.
Open PANW on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
